Wells Fargo analyst Stephen Baxter raised the firm’s price target on Humana (HUM) to $315 from $290 and keeps an Overweight rating on the ...

Wells Fargo analyst Steve Baxter maintained a Buy rating on Humana (HUM – Research Report) today and set a price target of $315.00. The ...

Artisan Partners, an investment management company, released its “Artisan Value Fund” third quarter 2024 investor letter. A ...

Company officials said Monday they are not pursuing a merger with rival Humana, causing Cigna's stock to rise in the markets.

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.25% of ...

UnitedHealth Group Inc. shares rose as much as 9.3% before U.S. markets opened, while shares of Humana Inc. gained as much as ...

You don't need an exchange or wallet to invest in cryptocurrency anymore. These ETFs can provide crypto exposure in a regular brokerage account.

Since the start of the year, Humana stock is underperforming with a 39.4% deficit ... Numerous companies with connections to ...

Asian shares are trading mostly lower, despite a rally on Wall Street in stocks seen as benefiting the most from Donald Trump’s reelection as president ...

Tesla was the strongest force pushing the S&P 500 higher after rising 6.9%. Its leader, Elon Musk, has become a close ally of Trump’s, and its stock jumped nearly 15% the day af ...

Cigna Group said on Monday it is not pursuing a combination with rival health insurer Humana, days after Donald Trump's reelection as U.S. president raised investor hopes that any merger would ...